Admin

New Delhi: India is third after China and the United States in the prevalence of cancer across the world, and the country is likely to have around 2 million cases by 2040, Minister of State in the Prime Minister's Office Jitendra Singh informed the Rajya Sabha on Thursday.
Responding to supplementaries during the Question Hour, the minister informed the house that the Department of Biotechnology has developed the first-ever HPV vaccine for the treatment of cervical cancer in women, and the government is working to make it available to a larger population at an affordable rate or free of cost.
It is true that cancer incidence has increased all over the world. If you take the world statistics, we have 20 million cancer patients every year, that is around 2 crore cancer patients every year. In India alone, we have about 1.4 to 1.5 million, which is almost 15 lakh.
The figure is expected to go up to almost 2 million by 2040 or so, which means nearly 20 lakh. We stand at number 3, after China and the USA, as far as the prevalence of cancer is concerned," Singh told the Rajya Sabha.

Responding to supplementaries during the Question Hour, the minister informed the house that the Department of Biotechnology has developed the first-ever HPV vaccine for the treatment of cervical cancer in women.

Cancer patients in India could rise to 2 million by 2040: MoS Jitendra Singh

Get your personalized news feed with the Premium content

Premium Plan

https://5whapi.checksample.in/news/1766118265463.webp

https://5whapi.checksample.in/newsdetail/cancer-patients-india-rise-million-2040-mos-jitendra-singh

Cancer patients in India could rise to 2 million by 2040: MoS Jitendra Singh

Responding to supplementaries during the Question Hour, the minister informed the house that the Department of Biotechnology has developed the first-ever HPV vaccine for the treatment of cervical cancer in women.

Related Topics

Recent News